Skip to content

Effects of preemptive analgesia on CRP and HMGB1 in patients with lower extremity orthopedic surgery

Effects of preemptive analgesia on CRP and HMGB1 in patients with lower extremity orthopedic surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058758
Enrollment
Unknown
Registered
2022-04-16
Start date
2022-04-03
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower extremity trauma

Interventions

Group 1 :Parecoxib sodium preemptive analgesia
Group 2:Preemptive analgesia with flurbiprofen axetil
Group 3:Ketorolac tromethamine preemptive analgesia

Sponsors

Affiliated Hospital of Yan'an University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing lower extremity orthopedic surgery under combined spinal-epidural block anesthesia; 2. American Society of Anesthesiologists (ASA) classification I-II; 3. Age 18-65 years old, BMI between 18.5-23 kg/m2; 4. Heart, lung, liver, and kidney functions without abnormality, immunity, blood system, and blood coagulation function without abnormality; 5. No infectious disease; 6. Non-NSAIDs contraindications; 7. The patient is informed and agrees to receive blood test and drug treatment plan, and sign the informed consent form; 8. Not participating in other clinical research.

Exclusion criteria

Exclusion criteria: 1. People who are allergic to NSAIDs; 2. Use PCIA lost patients or follow up lost patients; 3. Operation time > 2 hours.

Design outcomes

Primary

MeasureTime frame
C-reactive protein concentration;High mobility histone B1 levels;Visual Analogue Scale (VAS) score;

Secondary

MeasureTime frame
Intraoperative adverse reactions ;48h postoperative comfort score (Bruggrmann comfort scale);Occurrence of postoperative complications;

Countries

China

Contacts

Public ContactLingxia Li

Affiliated Hospital of Yan'an University

Llx2381630@163.com+86 18091150098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026